Provided by Tiger Fintech (Singapore) Pte. Ltd.

Islamic Stocks

3,563.10
+68.321.95%
Number of Gainers:12
Number of Losers:5
Number of Flat:- -
PE:- -
High:3,572.32
Open:3,496.70
Low:3,496.70
Close:3,494.78
Loading ...

Pfizer announces Phase 3 CREST trial met primary endpoint of EFS

TIPRANKS
·
1 hour ago

Abbott announces new AVEIR data, initiates trial for pacing technology

TIPRANKS
·
1 hour ago

Abbott announces new data from its Volt CE Mark Study

TIPRANKS
·
1 hour ago

Johnson & Johnson announces new data from Cohort 2 of Phase 2b SunRISe-1

TIPRANKS
·
1 hour ago

Exxon Mobil Corporation (XOM): Among the Most Profitable Blue Chip Stocks to Buy Now

Insider Monkey
·
3 hours ago

Jim Cramer Says You Should Buy Johnson & Johnson (JNJ), Thinks Talc Problems ‘Behind It’

Insider Monkey
·
3 hours ago

Is Microsoft (MSFT) Among the Best Self-Driving Car Stocks to Buy According to Analysts?

Insider Monkey
·
4 hours ago

Can Tesla Stock Help Make You a Millionaire?

Motley Fool
·
5 hours ago

Jim Cramer Says ‘When Tesla Inc. (TSLA) Goes Down It Tends To Hurt Everything Related’

Insider Monkey
·
Yesterday

1 Wall Street Analyst Thinks Apple Is Going to $254. Is It a Buy Around $200?

Motley Fool
·
Yesterday

Down Nearly 30% in 2025: Is Reddit Stock a Buy?

Motley Fool
·
Yesterday

1 Incredible Artificial Intelligence (AI) Stock Down 29% to Buy Right Now

Motley Fool
·
Yesterday

2 Top Artificial Intelligence Stocks to Buy While They're on Sale

Motley Fool
·
Yesterday

BRIEF-Abbott Laboratories Says New Clinical Study Data Showcase Long-Term, Sustained Benefits Of Abbott's Volt™ Pfa System For Patients With Afib

Reuters
·
Yesterday

Abbott Laboratories - Volt Pfa System Shows Strong 12-Month Results

THOMSON REUTERS
·
Yesterday

Abbott Laboratories - Only 2.7% Experienced Safety Endpoint Event After 12 Months

THOMSON REUTERS
·
Yesterday

Abbott Laboratories - 83.5% Paf and 58.1% Persaf Patients Arrhythmia-Free After 12 Months

THOMSON REUTERS
·
Yesterday

New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ Pfa System for Patients With Afib

THOMSON REUTERS
·
Yesterday

New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFib

PR Newswire
·
Yesterday

Tesla Cybertruck owner gets stuck after beliving Elon Musk’s ‘river crossing’ claim

Electrek
·
Yesterday